Ryan Z. Swan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ryan Z. Swan has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- John Bennett Martinie
Division of HPB Surgery, Department of Surgery, Carolinas Medical Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC, USA.
6 shared publications - David Anthony Iannitti
Carolinas Medical Center, Charlotte, NC, USA
3 shared publications David Sindram
Carolinas Medical Center, Charlotte, NC
3 shared publicationsAmanda L. Walters
Division of Gastrointestinal and Minimally Invasive Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC
2 shared publicationsRamanathan Seshadri
Division of Hepatopancreatobiliary Surgery, Department of Surgery, Carolinas Medical Center, Charlotte, NC
2 shared publicationsAmanda Walters
1 shared publication
Latest Publications
- 1 October 2014
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 219 (4) , e106-e107
Impact of race and socioeconomic status on survival following the surgical treatment of early stage hepatocellular carcinoma (HCC) – a retrospective analysis from the National Cancer Data Base
- 1 October 2014
- Published by Wolters Kluwer Health in Journal of the American College of Surgeons
- Vol. 219 (4) , e106-e107
Impact of race and socioeconomic status on survival following the surgical treatment of early stage hepatocellular carcinoma (HCC) – a retrospective analysis from the National Cancer Data Base
- 1 September 2014
- Published by Elsevier in The American Journal of Surgery
- Vol. 208 (3) , 350-362
Outcomes of pancreatic debridement in acute pancreatitis: analysis of the nationwide inpatient sample from 1998 to 2010
- 1 September 2014
- Published by Elsevier in The American Journal of Surgery
- Vol. 208 (3) , 350-362
Outcomes of pancreatic debridement in acute pancreatitis: analysis of the nationwide inpatient sample from 1998 to 2010
- 1 February 2013
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (4) , 218
Microwave ablation for hepatic malignancies: A multi-institutional analysis.
218 Background: Although many hepatobiliary centers have moved from radiofrequency ablation to microwave ablation (MWA), the factors that influence local control with MWA are not well described. We hypothesized that tumor size, number of tumors, and tumor histology significantly affected MWA success and recurrence-free survival (RFS). Methods: Consecutive patients with hepatic malignancy treated by MWA were included from 4 high-volume institutions (2003-2011), and grouped by histology: hepatocellular cancer (HCC), colorectal metastases (CM), neuroendocrine metastases (NM), and other cancers. Independent significance of variables was established with logistic regression and Cox proportional hazards models. Results: Four-hundred seventy three ablation procedures were performed (139 HCC, 198 CM, 61 NM, and 75 other) for a total of 875 tumors. Median follow-up was 18 months. Complete ablation was confirmed for 839 of 865 tumors (97.0%) on follow-up cross-sectional imaging (Table). NM had greater odds of an incomplete ablation compared to other histologies (odds ratio: 3.07, 95% confidence interval [CI]: 1.08-8.67, p=0.035), however this was not significant in adjusted models. The local recurrence rate was 6.1% overall, and was highest for HCC tumors (10.3%, p=0.051). RFS did not vary significantly between histologies. In adjusted models, tumor size ≥3cm was the only variable predicting poorer RFS (hazard ratio: 1.60, 95% CI: 1.02-2.50, p=0.039). Independent predictors of poorer OS included age, number of tumors ablated, and tumor size ≥3cm. Conclusions: In this large dataset, patients with ≥3cm tumors showed a propensity for early recurrence, regardless of histology. Higher rates of local recurrence were noted in HCC patients, which may reflect underlying liver disease. Accounting for recurrence at any site, however, there were no significant differences in RFS between tumor histologies. [Table: see text]
- 1 February 2013
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 31 (4) , 218
Microwave ablation for hepatic malignancies: A multi-institutional analysis.
218 Background: Although many hepatobiliary centers have moved from radiofrequency ablation to microwave ablation (MWA), the factors that influence local control with MWA are not well described. We hypothesized that tumor size, number of tumors, and tumor histology significantly affected MWA success and recurrence-free survival (RFS). Methods: Consecutive patients with hepatic malignancy treated by MWA were included from 4 high-volume institutions (2003-2011), and grouped by histology: hepatocellular cancer (HCC), colorectal metastases (CM), neuroendocrine metastases (NM), and other cancers. Independent significance of variables was established with logistic regression and Cox proportional hazards models. Results: Four-hundred seventy three ablation procedures were performed (139 HCC, 198 CM, 61 NM, and 75 other) for a total of 875 tumors. Median follow-up was 18 months. Complete ablation was confirmed for 839 of 865 tumors (97.0%) on follow-up cross-sectional imaging (Table). NM had greater odds of an incomplete ablation compared to other histologies (odds ratio: 3.07, 95% confidence interval [CI]: 1.08-8.67, p=0.035), however this was not significant in adjusted models. The local recurrence rate was 6.1% overall, and was highest for HCC tumors (10.3%, p=0.051). RFS did not vary significantly between histologies. In adjusted models, tumor size ≥3cm was the only variable predicting poorer RFS (hazard ratio: 1.60, 95% CI: 1.02-2.50, p=0.039). Independent predictors of poorer OS included age, number of tumors ablated, and tumor size ≥3cm. Conclusions: In this large dataset, patients with ≥3cm tumors showed a propensity for early recurrence, regardless of histology. Higher rates of local recurrence were noted in HCC patients, which may reflect underlying liver disease. Accounting for recurrence at any site, however, there were no significant differences in RFS between tumor histologies. [Table: see text]
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Adrenocortical Carcinoma With Intracaval Extension to the Right Atrium: Resection on Cardiopulmonary Bypass
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Adrenocortical Carcinoma With Intracaval Extension to the Right Atrium: Resection on Cardiopulmonary Bypass
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
The Impact of Regionalization of Pancreaticoduodenectomy for Pancreatic Cancer in North Carolina Since 2004
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
The Impact of Regionalization of Pancreaticoduodenectomy for Pancreatic Cancer in North Carolina Since 2004